pd-l1 biomarker testing
Published 7 years ago • 724 plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
0:55
challenges associated with biomarker testing for pd-l1 in nsclc
-
1:20
how does pd-l1 impact treatment options for lung cancer?
-
4:27
understanding immunotherapy for nsclc with pd-1 and pd-l1 biomarkers
-
10:20
pd-l1 testing in advanced lung cancer
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
3:21
pd-l1/pd-1 pathway: a security checkpoint
-
1:02:49
pd-l1/pd-1 cancer immunotherapy and new targets - gordon freeman, phd
-
2:15
what is biomarker testing?
-
1:34
evolving role of pd-l1 as a biomarker
-
1:00
dr. mason on the reliability of the pd-l1 biomarker
-
1:55
dr. hirsch on value of pd-l1 testing in patients with lung cancer
-
18:58
pd-l1 testing by immunohistochemistry
-
5:41
pd-l1 biomarker status: to test or not to test? (part 1)
-
1:41
dr. goldberg on pd-l1 as a biomarker in lung cancer
-
4:50
nsclc: challenges with pd-l1 as biomarker
-
9:54
is the pd-l1 biomarker ready for prime time?
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
3:50
the role of pd-l1: is it accurate enough as a biomarker for immunotherapy response?
-
1:00
dr. naidoo discusses biomarker testing for checkpoint inhibitors
-
0:53
pd-l1 biomarker status: to test or not to test? (conclusion)
-
0:52
pd-l1 biomarker status: to test or not to test? (introduction)
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer